As a summer of blockbuster Japanese-foreign market pharma deals fades away, Shionogi & Co. ended the active season with a bang in early September when it announced its acquisition of Atlanta-based Sciele Pharma Inc. in an all-cash deal valued at $1.4 billion.
Every now and then, I find it is helpful to simply clear my head of random thoughts that are jangling around inside my head that have been suggested by the work I do or simply what I see in my everyday life. As the election rolls around this year, it is apparent of the many things that separate the major candidates, there is very little either Obama or McCain disagree about that will have any kind of profound affect on the pharmaceutical and biotech industry.
It appears that no matter who wins the presidential election this November, both Barack Obama and John McCain back expanded use of generic drugs as a way to lower drug costs. According to their advisers, both campaigns have pledged their support to help create a market for generic biotech drugs or biosimilars.
Just as the general public receives its news from many “touch points” like newspapers, TV, radio and the Internet, DDN delivers the news of the pharmaceutical industry through several different sources, both print and online. We offer these multi-vehicle integrated sources to deliver news for our readers—as well as integrated marketing programs for advertisers. Several research studies confirm the value of integrated news and marketing.